A prolonged disease trajectory complicates “survivor” identity, particularly when remission follows transplant yet later ...

Human cohort studies and meta-analyses have not shown increased incidence of common differentiated thyroid cancers with GLP-1 receptor agonist exposure. Rodent C-cell tumor signals underpin the boxed ...

The FDA has accepted a sNDA for Ameluz topical gel, used in combination with the RhodoLED red-light lamp series, for superficial basal cell carcinoma treatment.

With this decision, Optune Pax becomes the first new FDA-approved treatment for locally advanced pancreatic cancer in decades. For patients and families navigating this diagnosis, the addition of a ...

Chris Draft said patients with lung cancer and their caregivers can regain control after diagnosis by showing up, staying ...

While cranial radiation therapy (CRT) remains a major risk factor — with high doses of radiation showing a hazard ratio of ...

Scalp cooling during chemotherapy can be pivotal for AYA identity preservation and psychosocial functioning, facilitating ...

Colleen Mabasa, a patient with multiple myeloma, sat down with CURE for an interview to discuss how she pursued chimeric antigen receptor (CAR)-T cell therapy, navigated insurance and logistical ...

The FDA has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneous, chemo-free treatment for patients with EGFR-mutated non-small cell lung cancer across all ...

Cancer is a major thief. The disease can take your hair, your fingernails, your energy, your appetite. The list goes on and ...

The FDA approved protocol updates to a tasquinimod trial in myelofibrosis, allowing broader enrollment and combination use ...

FDA approved a PD-L1 companion test to identify patients with ovarian, fallopian tube or primary peritoneal cancer who may receive first-line Keytruda. The U.S. Food and Drug Administration (FDA) has ...